Registration Questions

Call: 202-684-2034
Email: eventregistration@bisnow.com

Request Speaker Information

Speaker Topics

Tell us a Little More

Speakers and Panels

Xave Jacoby

Xave Jacoby

Managing Director

King Street Properties

Morgan Weinstein

Morgan Weinstein

EVP, Northeast Region

Phase 3 Real Estate Partners

Chris Maciejczak

Chris Maciejczak

SVP, Life Sciences

The Lightstone Group

Matt DeNoble

Matt DeNoble

Senior Director, Life Science Investment Management

Greystar

Jeanne LeClair

Jeanne LeClair

Chief Business Officer

MLSC

John Sullivan

John Sullivan

President of Architecture, Partner

SGA

Matt DeNoble

Senior Director, Life Science Investment Management

Greystar

Matt oversees Bulfinch’s Asset Management Team, working closely with Financial Reporting and Acquisitions to ensure the success of the firm’s portfolio management and growth.

Jeanne LeClair

Chief Business Officer

MLSC

Jeanne joined the MLSC in October 2020 and currently serves as the Chief Business Officer. In this role, she develops and executes strategies to enhance life sciences job growth in the Commonwealth by building relationships with key industry stakeholders, workforce training partners, and public agencies.

Prior to joining the MLSC, Jeanne served as the Economic Development Director for the Gateway Hilltown Collaborative, a pilot program unifying community development efforts in six small towns in Western Massachusetts. Jeanne earned her BA from Boston University, and worked at the Cambridge-based political magazine Boston Review. She received her Masters in Public Policy and Masters in Business Administration from the Heller School for Social Policy and Management at Brandeis University, where she focused her efforts on entrepreneurship, economic justice, and community development. After graduate school, she worked at the Boston Public Market in a variety of roles including business operations. Jeanne originally hails from the small town of Clarksville, Missouri where she grew up on a working farm. She enjoys playing music, collecting vintage NASA memorabilia, and running with her Sheprador.

John Sullivan

President of Architecture, Partner

SGA

John, an equal majority owner of SGA, spearheads the firm’s architecture practice, encompassing the life sciences, academic, commercial, technology, and residential markets. Known as a design innovator and thought leader, John leads many of the firm’s valued client relationships. Using his creativity, knowledge and strong communication skills, he has generated award-winning design concepts and has achieved public approvals for SGA’s largest and complex projects.

With over 16 years at SGA, John oversees the firm’s large-scale projects in both urban and suburban settings. He plays a major role in master planning, conceptual design, and the entitlements process, welcoming opportunities to present the perspective of clients to generate consensus among communities, municipalities and key stakeholders.

John’s talent for placemaking and architectural innovation has broadened recognition for SGA’s approach to design. Within the firm, John is a champion for design and an advocate for SGA’s culture, with an ongoing focus on fostering a supportive environment where people can thrive and grow as design professionals.

John received a Bachelor and Master of Architecture from Virginia Tech. Outside of the office, he spends time with his wife, two sons, and dog Brenna, who is a lab mix. He and his family enjoy traveling, the beach, and sports – they support Boston’s pro teams, his sons’ youth teams, and their alma maters, Virginia Tech and Ohio State.

Why You Should Attend This 2026 Boston Biotech Summit

What You'll Learn:

  • With 76% of first half biotech venture dollars going to later rounds, how do smaller companies compete ?

  • How is Boston’s biotech ecosystem continuing to foster innovation, and what distinctive advantages will support its rebound?

  • Massachusetts startups raised $10.2B in the first half of 2026. Where is that capital landing?

  • Are venture backed startups still the demand engine here, or has big pharma become the market's steadier tenant?

  • Boston still asks $76.72 per SF against $64.30 in San Diego. Is that premium defensible in 2027?

  • How is technology driving the demand for flexible, adaptable labs and GMP facilities that can evolve with science?

  • In what ways has tenant demand for modular layouts, spec suites, and shorter lease terms reshaped leasing dynamics in 2026?

  • Owners are investing in prebuilt lab suites and marketing beyond life sciences users. Is this approach is actually working?

How you'll do more business:

Connect with the industry leaders setting terms in Greater Boston right now. Understand what the current funding environment means for tenant quality, deal size and how long a company can commit. Gain insight into the manufacturing capabilities, GMP requirements and lab specifications that determine which buildings win real activity. Explore how owners are using rent, concessions and lease structure to compete in a tenant favorable market, and leave with a clearer read on where leverage sits heading into 2027. 

Who attends:

Investors, owners, developers, tenants, end users, brokers, lawyers, designers, contractors, architects, property managers and more!

Why should you attend:

Bisnow events bring together the biggest power players in the industry to identify opportunities, build your network, and expand your business. With the largest audience of commercial real estate professionals in the world, no one knows how to help your business more than us.

For questions, recommendations, comments, or press inquiries please email our Senior Event Producer, Joshua Piquion at Joshua.Piquion@bisnow.com.

To request disability-related accommodations, please contact audrey.sullivan@bisnow.com no later than seven business days prior to the event.

Agenda

Time Activity
8:00 AM
9:00 AM
Coffee, Breakfast & Networking
9:00 AM
9:45 AM
Evolving Trends In Funding, Workforce Development & Scientific Innovation

1.) Examine what a reopened IPO window means for expansion timing versus extended runway.
2.) Discuss how AI enabled discovery and new modalities are reshaping company facility requirements.

9:45 AM
10:00 AM
Networking Break
10:00 AM
10:45 AM
What Tenants Want: Manufacturing & Lab Building Features Driving Demand

1.) Identify the lab space and specifications tenants prioritize when comparing available options.
2.) Examine where GMP and manufacturing requirements diverge from research space needs.

10:45 AM
11:30 AM
Deal Environment and Leasing Strategies In Today's Market

1.) Discuss Investment opportunities and what types of labs owners are trading on today.
2.) Examine leasing environment and types of tenants actively looking for space.

11:30 AM
11:45 AM
Post-Event Networking

Tickets

Super Early Bird

$120.00 /ticket

Save the most by registering now!

Sponsors